Stock listing

ARDX Stock Price, News, Filings & Events — Ardelyx, Inc.

Selected listing: ARDX · NASDAQ · USD · US

This page tracks Ardelyx, Inc.'s ARDX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ARDX:NASDAQ. ARDX:NASDAQ is the stock-level entry point for investors researching Ardelyx, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ardelyx, Inc. is a public company traded on the American stock market under the ticker ARDX. With a market capitalization of approximately $1.24 billion, Ardelyx focuses on developing innovative therapies for gastrointestinal and renal diseases. The company is committed to advancing its pipeline to address unmet medical needs in these areas.

ARDX:NASDAQUSDUSUpdated August 28, 2026
Ardelyx, Inc. logo
Ticker
ARDX:NASDAQ
Asset type
Stock
Market cap
$949.4M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD

Ardelyx, Inc. ARDX:NASDAQ stock context

This page tracks Ardelyx, Inc.'s ARDX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ARDX:NASDAQ. ARDX:NASDAQ is the stock-level entry point for investors researching Ardelyx, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ardelyx, Inc. is a public company traded on the American stock market under the ticker ARDX. With a market capitalization of approximately $1.24 billion, Ardelyx focuses on developing innovative therapies for gastrointestinal and renal diseases. The company is committed to advancing its pipeline to address unmet medical needs in these areas.

Latest news from Ardelyx, Inc.

All Ardelyx, Inc. news →

Ardelyx, Inc. earnings calls

Research Ardelyx, Inc.

Alternate listings